Subscale Validation of the Neuropsychiatric Inventory Questionnaire: Comparison of Alzheimer's Disease Neuroimaging Initiative and National Alzheimer's Coordinating Center Cohorts
Paula T. Trzepacz(Eli Lilly (United States)), Jeffrey L. Cummings(University of Nevada, Las Vegas), Peng Yu(Eli Lilly (United States)), Brian A. Willis(Eli Lilly (United States)), Jia Sun(Beike Biotechnology (China)), Ellen B. Dennehy(Eli Lilly (United States)), Phani Bhamditipati(Eli Lilly (United States)), Andrew J. Saykin(Indiana University School of Medicine)
Cited by 51
Related Papers
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
|Psychological Medicine|2004|989
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
|Alzheimer s & Dementia|2018|690